Related references
Note: Only part of the references are listed.Fighting fire with fire: The immune system might be key in our fight against Alzheimer's disease
Pieter Dujardin et al.
DRUG DISCOVERY TODAY (2022)
Challenges and hopes for Alzheimer's disease
Suren A. Tatulian
DRUG DISCOVERY TODAY (2022)
Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease
Dan Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon Irradiation
Matthias Scheiner et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series
Anze Meden et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer?s disease
Honghua Zhang et al.
BIOORGANIC CHEMISTRY (2022)
AD Hypotheses and Suggested Clinical Trials
Pravat K. Mandal et al.
ACS CHEMICAL NEUROSCIENCE (2021)
N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects
Yinliang Bai et al.
BIOORGANIC CHEMISTRY (2021)
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease
Francois-Xavier Toublet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease
Afzal Misrani et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model
Matthias Scheiner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential
Vivek Kumar Sharma et al.
NEUROCHEMICAL RESEARCH (2021)
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
Giselle de Andrade Ramos et al.
RSC MEDICINAL CHEMISTRY (2021)
Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors
Weiwei Ma et al.
CARBOHYDRATE RESEARCH (2020)
Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation
Xiaohong Fan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases
Tim Bartels et al.
SCIENCE (2020)
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff et al.
CHEMICAL REVIEWS (2019)
Harnessing Polypharmacology with Medicinal Chemistry
Maria Laura Bolognesi
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer's Disease Studies
Liana M. de Medeiros et al.
MOLECULAR NEUROBIOLOGY (2019)
Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease
Zhipei Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model
Matthias Hoffmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors
Lanlan Jing et al.
DRUG DISCOVERY TODAY (2019)
Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies
Huseyin Cavdar et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity
Urban Kosak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities
Damijan Knez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Neuroinflammation, Gut Microbiome, and Alzheimer's Disease
Li Lin et al.
MOLECULAR NEUROBIOLOGY (2018)
Alzheimer's disease hypothesis and related therapies
Xiaoguang Du et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Lidia Blanco-Silvente et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
The SH-SY5Y cell line in Parkinson's disease research: a systematic review
Helena Xicoy et al.
MOLECULAR NEURODEGENERATION (2017)
Alzheimer's Disease: A Systemic Review of Substantial Therapeutie Targets and the Leading Multi-functional Molecules
Tarana Umar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al.
ALZHEIMERS & DEMENTIA (2016)
Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Dario Tejera et al.
CURRENT ALZHEIMER RESEARCH (2016)
Alzheimer's Disease: Targeting the Cholinergic System
Talita H. Ferreira-Vieira et al.
CURRENT NEUROPHARMACOLOGY (2016)
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode
Edgar Sawatzky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
Urban Kosak et al.
SCIENTIFIC REPORTS (2016)
Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions
James Varley et al.
ALZHEIMERS & DEMENTIA (2015)
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
Xinglong Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?
Ian R. Macdonald et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Apoptosis in Alzheimer's Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues
M. Obulesu et al.
NEUROCHEMICAL RESEARCH (2014)
The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
Silvia Sorce et al.
PLOS PATHOGENS (2014)
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer's Disease
Muriel Noetzli et al.
CLINICAL PHARMACOKINETICS (2013)
Growth inhibitory, apoptotic and anti-inflammatory activities displayed by a novel modified triterpenoid, cyano enone of methyl boswellates
Palaniyandi Ravanan et al.
JOURNAL OF BIOSCIENCES (2011)
Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties
Barbara Zapala et al.
PHARMACOLOGICAL REPORTS (2010)
Neurobiology of butyrylcholinesterase
S Darvesh et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine
MM Mesulam et al.
NEUROSCIENCE (2002)
Share Paper
